CN104041803A - Anti-senility plant stem cell lozenge and preparation method thereof - Google Patents
Anti-senility plant stem cell lozenge and preparation method thereof Download PDFInfo
- Publication number
- CN104041803A CN104041803A CN201310080993.3A CN201310080993A CN104041803A CN 104041803 A CN104041803 A CN 104041803A CN 201310080993 A CN201310080993 A CN 201310080993A CN 104041803 A CN104041803 A CN 104041803A
- Authority
- CN
- China
- Prior art keywords
- preparation
- lozenge
- stem cell
- plant stem
- ageing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000196324 Embryophyta Species 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000007937 lozenge Substances 0.000 title claims abstract description 15
- 210000000130 stem cell Anatomy 0.000 title claims abstract description 15
- 230000003005 anti-senility effect Effects 0.000 title abstract 2
- 239000002245 particle Substances 0.000 claims abstract description 18
- 229930182470 glycoside Natural products 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 11
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 10
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 claims abstract description 10
- 229930003944 flavone Natural products 0.000 claims abstract description 10
- -1 flavone glycoside Chemical class 0.000 claims abstract description 10
- 235000011949 flavones Nutrition 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000007779 soft material Substances 0.000 claims abstract description 7
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 6
- 229920002472 Starch Polymers 0.000 claims abstract description 6
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 6
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims abstract description 6
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 6
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 6
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 6
- 235000019698 starch Nutrition 0.000 claims abstract description 6
- 239000008107 starch Substances 0.000 claims abstract description 6
- 239000012153 distilled water Substances 0.000 claims abstract description 5
- 239000000080 wetting agent Substances 0.000 claims abstract description 5
- 238000001035 drying Methods 0.000 claims abstract description 4
- 229940032147 starch Drugs 0.000 claims abstract description 3
- 230000003712 anti-aging effect Effects 0.000 claims description 15
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 7
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 5
- 238000009288 screen filtration Methods 0.000 claims description 4
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 3
- 235000008696 isoflavones Nutrition 0.000 claims description 3
- 239000007791 liquid phase Substances 0.000 claims description 3
- 239000004744 fabric Substances 0.000 claims 1
- 230000001568 sexual effect Effects 0.000 abstract description 3
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 abstract description 2
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- 240000000759 Lepidium meyenii Species 0.000 abstract 1
- 235000000421 Lepidium meyenii Nutrition 0.000 abstract 1
- 235000016392 Myrciaria paraensis Nutrition 0.000 abstract 1
- 244000002791 Myrciaria paraensis Species 0.000 abstract 1
- KQNGHARGJDXHKF-UHFFFAOYSA-N dihydrotamarixetin Natural products C1=C(O)C(OC)=CC=C1C1C(O)C(=O)C2=C(O)C=C(O)C=C2O1 KQNGHARGJDXHKF-UHFFFAOYSA-N 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 235000012902 lepidium meyenii Nutrition 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 108010084210 citrin Proteins 0.000 description 2
- 230000000120 cytopathologic effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 229940007046 shigella dysenteriae Drugs 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000029162 bladder disease Diseases 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008125 glucin Substances 0.000 description 1
- 125000004383 glucosinolate group Chemical group 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000026533 urinary bladder disease Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an anti-senility plant stem cell lozenge and a preparation method thereof. The preparation method includes: taking flavone glycoside, taxifolin, Maca and Camu Camu fruits as raw materials, adding starch, low substituted hydroxypropyl cellulose and microcrystalline cellulose to form a mixture, stirring the mixture evenly, then adding ethanol or distilled water used as a wetting agent and performing stirring until uniform to make a soft material, then filtering out particles by a screen mesh, drying the particles, then adding magnesium stearate, mixing them evenly and conducting tabletting to obtain a finished product for oral administration. The product prepared by the method can extend people's life by 20-25 years, has the functions of resisting senility and tumors and inhibiting cell lesion, and can improve the sexual capacity.
Description
Technical field
Patent of the present invention relates to a kind of anti-ageing plant stem cell lozenge and preparation method thereof.
Background technology
Current: along with work, life stress increase, human body there will be inferior health or sick and even suffer from the sick situation such as tumour, existing for the sick rear most employing of human body be operation, have an injection and the way such as chemotherapy, the health bringing to patient and psychology are all very large miseries.
Patent of invention content
For overcoming above-mentioned defect, the purpose of design of patent of the present invention is to be to provide a kind of anti-ageing plant stem cell lozenge and preparation method thereof, the growth that can be used for preventing in advance resistance and check the cell that is unfavorable for human body.
For achieving the above object, patent object of the present invention is to provide a kind of anti-ageing plant stem cell lozenge and preparation method thereof; It adopts flavone glycoside, texifolin, agate coffee and Ka Mu fruit is raw material, by adding starch, low-substituted hydroxypropyl cellulose and microcrystalline cellulose to form mixture, after mixture stirs, add ethanol or distilled water to stir as wetting agent until evenly, be made into soft material, go out particle by screen filtration again, after adding dolomol to mix after particle is dried, be pressed into sheet and be made into finished product and orally use.The finished product of making by said method has the life 20-25 that makes people, staphylococcus aureus, Escherichia coli, shigella dysenteriae and typhoid bacillus are had to stronger bacteriostasis, can remove the free radical in the person, have anti-ageing, antitumor, suppress cytopathic function, can improve the male sex, women's sexuality, ensure the healthy stable state of sexual gland function.
Further, patent of the present invention adopts flavone glycoside 500g, texifolin 250-500g, the agate coffee 250-500g that is more than or equal to 98% concentration and Ka Mu fruit 500g are raw material, form mixture by the starch, 0.07-0.1kg low-substituted hydroxypropyl cellulose and the 01.1-0.6kg microcrystalline cellulose that add 2.5-5kg; After mixture is stirred, add ethanol or distilled water to stir as wetting agent until evenly, be made into soft material, soft material goes out particle by 14-20 object screen filtration, by dryer, particle is dried, after drying, the standard of particle is the water content of 3-10%, after adding dolomol 150-250g to mix, is pressed into sheet and is made into finished product and orally uses in the particle after oven dry.
Further, the temperature that in patent of the present invention, dryer is dried particle remains between 40-100 DEG C.
Further, in patent of the present invention, utilize and prepare high efficiency liquid phase spectroscopic methodology and from plant total isoflavone extract, prepared concentration and be more than or equal to 98% flavone glycoside.
Further, 1936, St.George's found chromocor compound-flavone glycoside, and naming it is citrin, and obtained the prize of Nobel's biology.Citrin and agate coffee are that raw material adopts international pharmacy forward position abstraction technique to be made, and are new resource food, the safety, healthy without any side effects of health ministry approval.Agate coffee is according to French Luo Gaite experimental determination: protein content exceedes 14%, 59% carbohydrate, 8.5% fiber, mineral matter, and containing vitamin C, B1, B2, B6, A, E, B12, B5, fat content is high but mostly wherein be unrighted acid, and the content of linoleic acid plus linolenic acid reaches more than 53%.Natural activity composition comprises alkaloid, glucosinolate and catabolite isothiocyanic acid benzyl fat, sterol, polyphenols, glycyrrhizic acid glucin, flavone glycoside, glycan, lecithin and sterol, plant VC etc.
Adopt that above-mentioned preparation method is simple to operate, safety, finished product can not only keep vascular wall to have good pliability, can also improve erythrocytic activity, make it increase oxygen carrier amount and metabolism amount, can suppress the adhesion between blood platelet, there is the sanguimotor function of improvement simultaneously; Can and treat diabetes, three high diseases, cholecystopathy, intestines and stomach, prostate, skin disease, kidney and bladder disease, ophthalmology disease etc. and inferior health for prevention, and improve the immune antitumor caused side effect of alleviation chemotherapy and radiation of playing; Can make people's life 20-25; Antibacterial: staphylococcus aureus, Escherichia coli, shigella dysenteriae and typhoid bacillus are had to stronger bacteriostasis; Remove free radical: it has multiple biologically active, can remove the free radical in the person, have anti-ageing, antitumorly, suppress cytopathic magical function; Improve fecundity: can improve the male sex, women's sexuality, ensure the healthy stable state of sexual gland function.
Brief description of the drawings
Fig. 1 is the making flow chart of patent of invention
Detailed description of the invention
Below in conjunction with accompanying drawing, patent of the present invention is described in detail.
As shown in Figure 1, anti-ageing plant stem cell lozenge of the one of patent of the present invention and preparation method thereof; It adopts 1 flavone glycoside 500g, 2 texifolin 250-500g, the 3 agate coffee 250-500g that are more than or equal to 98% concentration and 4 card nurse fruit 500g are raw material, form 8 mixtures by 5 starch, 0.07-0.1kg6 low-substituted hydroxypropyl cellulose and the 01.1-0.6kg7 microcrystalline cellulose that add 2.5-5kg; After 8 mixtures are stirred, add 9 ethanol or distilled water to stir as wetting agent until evenly, be made into 10 soft material, 10 soft material go out 12 particles by 14-20 object 11 screen filtrations, by 13 dryers, 12 particles are dried, after drying, the standard of 12 particles is water content of 3-10%, after adding 14 dolomol 150-250g to mix, is pressed into sheet and is made into 15 finished products and orally uses in 12 particles after oven dry.
Further, the temperature that in patent of the present invention, 13 dryers are dried 12 particles remains between 40-100 DEG C.
Further, in patent of the present invention, utilize and prepare high efficiency liquid phase spectroscopic methodology and from plant total isoflavone extract, prepared concentration and be more than or equal to 98% 1 flavone glycoside.
Further, using method: (first month) 1 time on the 1st, and each 2, containing clothes.1 time on the later 1st, each 1, containing clothes
Below be only that given with reference to the accompanying drawings embodiment makes specific descriptions; it is not the restriction of patent of the present invention being made to its form; concerning the technical scheme of this area, the amendment of making in the disclosed content basis of patent of the present invention, still belongs to the protection domain of patented technology scheme of the present invention.
Claims (8)
1. anti-ageing plant stem cell lozenge and preparation method thereof; It adopts flavone glycoside, texifolin, agate coffee and Ka Mu fruit is raw material, by adding starch, low-substituted hydroxypropyl cellulose and microcrystalline cellulose to form mixture, after mixture stirs, add ethanol or distilled water to stir as wetting agent until evenly, be made into soft material, go out particle by screen filtration again, after adding dolomol to mix after particle is dried, be pressed into sheet and be made into finished product.
2. anti-ageing plant stem cell lozenge of one according to claim 1 and preparation method thereof, it is characterized in that described flavone glycoside is 500g, the agate coffee that texifolin is 250-500g, be more than or equal to 98% concentration be 250-500g and Ka Mu fruit for 500g be raw material.
3. anti-ageing plant stem cell lozenge of one according to claim 1 and preparation method thereof, is characterized in that described starch is that 2.5-5kg, low-substituted hydroxypropyl cellulose are that 0.07-0.1kg and microcrystalline cellulose are 01.1-0.6kg.
4. anti-ageing plant stem cell lozenge of one according to claim 1 and preparation method thereof, is characterized in that described screen cloth is 14-20 order.
5. anti-ageing plant stem cell lozenge of one according to claim 1 and preparation method thereof, the standard that it is characterized in that drying rear particle is the water content of 3-10%.
6. anti-ageing plant stem cell lozenge of one according to claim 1 and preparation method thereof, is characterized in that described dolomol is 150-250g.
7. anti-ageing plant stem cell lozenge of one according to claim 1 and preparation method thereof, is characterized in that the temperature that described dryer is dried particle remains between 40-100 DEG C.
8. anti-ageing plant stem cell lozenge of one according to claim 1 and preparation method thereof, is characterized in that preparing high efficiency liquid phase spectroscopic methodology and from plant total isoflavone extract, has prepared concentration and be more than or equal to 98% flavone glycoside.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310080993.3A CN104041803B (en) | 2013-03-14 | 2013-03-14 | A kind of anti-ageing plant stem cell lozenge and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310080993.3A CN104041803B (en) | 2013-03-14 | 2013-03-14 | A kind of anti-ageing plant stem cell lozenge and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104041803A true CN104041803A (en) | 2014-09-17 |
| CN104041803B CN104041803B (en) | 2015-12-02 |
Family
ID=51495670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310080993.3A Expired - Fee Related CN104041803B (en) | 2013-03-14 | 2013-03-14 | A kind of anti-ageing plant stem cell lozenge and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104041803B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11872258B2 (en) * | 2018-12-06 | 2024-01-16 | Stemstix, Inc. | Oral cavity treatments |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101317665A (en) * | 2007-06-04 | 2008-12-10 | 冷雪飞 | Alkalescent high-energy agent for health and long life of human |
| CN102318795A (en) * | 2011-10-19 | 2012-01-18 | 郭景龙 | Health-care food having anti-fatigue function |
| CN102949431A (en) * | 2012-11-01 | 2013-03-06 | 上海中海龙高新技术研究院 | Maca buccal tablets and preparation method thereof |
-
2013
- 2013-03-14 CN CN201310080993.3A patent/CN104041803B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101317665A (en) * | 2007-06-04 | 2008-12-10 | 冷雪飞 | Alkalescent high-energy agent for health and long life of human |
| CN102318795A (en) * | 2011-10-19 | 2012-01-18 | 郭景龙 | Health-care food having anti-fatigue function |
| CN102949431A (en) * | 2012-11-01 | 2013-03-06 | 上海中海龙高新技术研究院 | Maca buccal tablets and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11872258B2 (en) * | 2018-12-06 | 2024-01-16 | Stemstix, Inc. | Oral cavity treatments |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104041803B (en) | 2015-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kiew et al. | Jewel of the seabed: sea cucumbers as nutritional and drug candidates | |
| CN101664428B (en) | Broccoli polyphenol capsules | |
| CN104543834A (en) | Pumpkin powder with blood sugar reducing effect and preparation method thereof | |
| CN104322630A (en) | Konjac soda biscuits and production process thereof | |
| CN101554362A (en) | Composition of natural product and preparation thereof | |
| CN102178162A (en) | Shepherd's purse noodles | |
| CN104489457A (en) | Dietary formula containing chitosan oligosaccharide and cordyceps militaris powder for liver cancer patients | |
| CN102443529B (en) | Rosemary healthcare medicinal liquor | |
| CN104041803B (en) | A kind of anti-ageing plant stem cell lozenge and preparation method thereof | |
| CN101642251A (en) | Nutritive rice suitable for middle-aged and elderly people and processing method thereof | |
| CN101142993A (en) | Fast pickling method for low-salt functional pickled vegetable | |
| CN103238713B (en) | Food healthy tea granule capable of tonifying and nourishing heart | |
| CN105410892A (en) | Insect active protein powder | |
| CN102524636A (en) | Health food for expelling toxin, relaxing bowels and preventing intestinal tumors | |
| CN103783377B (en) | A kind of highland barley health-care powder and preparation method thereof | |
| CN108175004A (en) | It is a kind of suitable for beverage of diabetic and preparation method thereof | |
| CN104286243A (en) | Selenium-enriched heart-nourishing tea and production method thereof | |
| CN103120308B (en) | Nutritional instant food and preparation method thereof | |
| CN105105120A (en) | Maca healthcare product | |
| KR102490378B1 (en) | Composition for enhancement of exercise performance comprising Gynostemma pentaphyllum extracts as an active ingredient | |
| CN106306179A (en) | Healthy Pu'er tea to lower blood sugar, blood fat and blood pressure | |
| CN103610063B (en) | Kenneth Lonergan marrow mixture and preparation method thereof | |
| CN105558148A (en) | Anticancer and caner preventing healthcare tea and manufacturing technology thereof | |
| CN104382177A (en) | Functional health-care granules containing Canna indica | |
| Pandia et al. | Research regarding the usage of the capsaicin-corn flour-ethylic alcohol in the naturist treatments. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Ye Ning Document name: Notification of Passing Examination on Formalities |
|
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Ye Ning Document name: Notification of Publication of the Application for Invention Addressee: Ye Ning Document name: Notification of Patent Invention Entering into Substantive Examination Stage |
|
| ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU DANXI BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: YE NING Effective date: 20150217 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 314199 JIAXING, ZHEJIANG PROVINCE TO: 510507 GUANGZHOU, GUANGDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150217 Address after: 510507 C08 room, two floor, Xinghua Road, No. 30, Xinghua Road, Guangdong, Guangzhou, Tianhe District Applicant after: GUANGZHOU DANXI BIOTECHNOLOGY CO., LTD. Address before: Jiashan County of Jiaxing City, Zhejiang province 314199 Weitang Town Ruixing Lily Spring District 6 Building 1 unit 603 room Applicant before: Ye Ning |
|
| ASS | Succession or assignment of patent right |
Owner name: YE NING Free format text: FORMER OWNER: GUANGZHOU DANXI BIOLOGICAL TECHNOLOGY CO., LTD. Effective date: 20150429 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 510507 GUANGZHOU, GUANGDONG PROVINCE TO: 100023 CHAOYANG, BEIJING |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150429 Address after: 100023, building 3, building 3, 209 broad road, Beijing, Chaoyang District Applicant after: Ye Ning Address before: 510507 C08 room, two floor, Xinghua Road, No. 30, Xinghua Road, Guangdong, Guangzhou, Tianhe District Applicant before: GUANGZHOU DANXI BIOTECHNOLOGY CO., LTD. |
|
| DD01 | Delivery of document by public notice |
Addressee: Ye Ning Document name: Notification of Passing Examination on Formalities |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151202 Termination date: 20200314 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |